Module 7 NURS 5334 exam with
complete solutions
Oral decongestants should be discouraged in patients with
•
A. migraines
•
B. allergic rhinitis
•
C. cardiovascular disease
•
D. chronic bronchitis - ANSWER- C. Cardiovascular disease
•
A 19 year old asthmatic is admitted to the ED in severe bronchospasm. The
NP should order:
•
A. nebulized beta 2 agonist
•
B. a salmeterol type inhaled agonist
•
C. an oral beta 2 agonist
•
D. an inhaled corticosteroid - ANSWER- A. nebulized beta 2 agonist
•
Regarding the use of long acting beta 2 agonists (LABAs), which of the
following is NOT true?
•
, A. LABAs enhance the anti inflammatory actions of corticosteroids
•
B. Use of LABAs is associated with small increase in risk of asthma death
•
C. LABA use reduces the risk of asthma exacerbations
•
D. LABAs can be used as monotherapy to relieve bronchospasms in asthma -
ANSWER- •
D. LABAs can be used as monotherapy to relieve bronchospasms in asthma
•
The antitussive dextromethorphan suppresses the cough reflex by:
•
A. Direct action on the cough center
•
B. Anesthetizing the alpha receptors
•
C. Causing CNS depression
•
D. Decreasing the viscosity of the bronchial sec - ANSWER- •
A. Direct action on the cough center
•
Your new 10 year old patient has asthma, and you decide to treat her with a
Beta 2 agonist. In considering the possible drug effects in the patient, you
would note the Beta 2 stimulants frequently cause:
•
A. Direct stimulation of the renin system
•
B. Hypoglycemia
•
C. Increased Histamine release
•
D. Increased pulse rate - ANSWER- D. Increased pulse rate
•
Tiotropium bromide is an inhaled anticholinergic:
•
A. Used for the treatment of COPD
•
B. Used in the treatment of asthma
complete solutions
Oral decongestants should be discouraged in patients with
•
A. migraines
•
B. allergic rhinitis
•
C. cardiovascular disease
•
D. chronic bronchitis - ANSWER- C. Cardiovascular disease
•
A 19 year old asthmatic is admitted to the ED in severe bronchospasm. The
NP should order:
•
A. nebulized beta 2 agonist
•
B. a salmeterol type inhaled agonist
•
C. an oral beta 2 agonist
•
D. an inhaled corticosteroid - ANSWER- A. nebulized beta 2 agonist
•
Regarding the use of long acting beta 2 agonists (LABAs), which of the
following is NOT true?
•
, A. LABAs enhance the anti inflammatory actions of corticosteroids
•
B. Use of LABAs is associated with small increase in risk of asthma death
•
C. LABA use reduces the risk of asthma exacerbations
•
D. LABAs can be used as monotherapy to relieve bronchospasms in asthma -
ANSWER- •
D. LABAs can be used as monotherapy to relieve bronchospasms in asthma
•
The antitussive dextromethorphan suppresses the cough reflex by:
•
A. Direct action on the cough center
•
B. Anesthetizing the alpha receptors
•
C. Causing CNS depression
•
D. Decreasing the viscosity of the bronchial sec - ANSWER- •
A. Direct action on the cough center
•
Your new 10 year old patient has asthma, and you decide to treat her with a
Beta 2 agonist. In considering the possible drug effects in the patient, you
would note the Beta 2 stimulants frequently cause:
•
A. Direct stimulation of the renin system
•
B. Hypoglycemia
•
C. Increased Histamine release
•
D. Increased pulse rate - ANSWER- D. Increased pulse rate
•
Tiotropium bromide is an inhaled anticholinergic:
•
A. Used for the treatment of COPD
•
B. Used in the treatment of asthma
